Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 4:46 pm Sale | 2021-01-31 | 13G | Cardiff Oncology, Inc. CRDF | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,290,000 (Position Closed) | Filing History |
| 2021-02-10 4:34 pm Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | RA CAPITAL MANAGEMENT L.P. | 289,516 6.400% | 289,516 (New Position) | Filing History |
| 2021-02-10 4:31 pm Purchase | 2020-12-31 | 13G | Keros Therapeutics, Inc. KROS | RA CAPITAL MANAGEMENT L.P. | 1,875,000 8.100% | 1,875,000 (New Position) | Filing History |
| 2021-02-08 5:16 pm Purchase | 2021-02-04 | 13G | Iterum Therapeutics plc ITRM | RA CAPITAL MANAGEMENT L.P. | 915,358 10.600% | 248,692 (+37.30%) | Filing History |
| 2021-01-29 4:30 pm Purchase | 2021-01-29 | 13G | CytomX Therapeutics, Inc. CTMX | RA CAPITAL MANAGEMENT L.P. | 3,500,000 5.800% | 3,500,000 (New Position) | Filing History |